Screener
Maze Therapeutics MAZE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's accounts payable?
- Maze Therapeutics (MAZE) reported accounts payable of $2.21M in Q2 2026.
- How has Maze Therapeutics's accounts payable changed year-over-year?
- Maze Therapeutics's accounts payable decreased by 39.7% year-over-year, from $3.67M to $2.21M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Maze Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude